Semi-mechanistic Efficacy Model for PARP + ATR Inhibitors—application to Rucaparib and Talazoparib in Combination with Gartisertib in Breast Cancer PDXs
British Journal of Cancer（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined